Navigation Links
IDEXX Laboratories Announces Fourth Quarter and Full Year Results
Date:1/27/2012

rily from higher sales and marketing personnel-related costs, partly offset by an incremental milestone payment earned during the quarter related to the 2008 sale of product rights previously included in our pharmaceutical product line, which was recorded as a reduction in expense. Research and development ("R&D") expense for the fourth quarter of 2011 was $20.2 million, or 7% of revenue, compared to $17.5 million, or 6% of revenue for the fourth quarter of 2010. The increase in R&D expense resulted primarily from increased personnel-related costs and higher external consulting and development costs.

Year-to-Date Results Revenues for the year ended December 31, 2011 increased 10% to $1.219 billion, from $1.103 billion for the year ended December 31, 2010. Organic revenue growth for the year ended December 31, 2011 was 8%. Changes in foreign currency exchange rates contributed 2% to revenue growth and revenue from acquisitions contributed less than 1% to revenue growth for the year ended December 31, 2011.

EPS for the year ended December 31, 2011 increased 17% to $2.78, compared to $2.37 for the same period in the prior year. 2011 EPS includes an aggregate of $4 million in payments relating to the sale of certain product rights and to the sale of certain raw material inventory in connection with the 2008 restructuring of our pharmaceutical business, which added $0.04 to EPS. 2010 EPS included similar milestone payments, which added $0.03 to EPS.

Supplementary Analysis of ResultsThe accompanying financial tables provide more information concerning our revenue and other operating results for the three and twelve months ended December 31, 2011.

Outlook for 2012The Company provides the following updated guidance for the full year of 2012. This guidance reflects an assumption that the value of the U.S. dollar relative to other currencies will remain at our current assumptions of the euro at $1.25, the British pound at $1.53 and
'/>"/>

SOURCE IDEXX Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. IDEXX Laboratories to Release 2009 Fourth Quarter and Full-Year Financial Results
2. IDEXX Laboratories Announces Catalyst Dx(R) Placement Total for 2009 and Installed Base of SmartService(TM) Customers
3. McAllister Software Systems, Inc. and IDEXX Laboratories, Inc. Announce Availability of the IDEXX VetLab(R) Station InterLink(TM) Connection to AVImark(R) 2010
4. NetMotion Wireless Tapped by IDEXX Laboratories to Provide Secure Mobile Access to Field Personnel
5. IDEXX Laboratories to Release 2011 Second Quarter Financial Results
6. IDEXX Laboratories Announces Third Quarter Results
7. IDEXX Laboratories to Present at J.P. Morgan Healthcare Conference
8. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
9. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
10. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
11. Romark Laboratories Raises $18 Million in Institutional Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... 2015 De toevoeging ... voor patiënten met niet-resectabele uitgezaaide colorectale kanker ... overleving in dat orgaan. Bij ... die alleen binnen de lever is uitgezaaid,werd ... (PFS) in de lever dankzij de toevoeging ...
(Date:7/3/2015)... -- A global continuing medical education provider ... disorders in Central and South-East Asia ... conference dedicated to these diseases.      (Logo: ... Manage Hypertension Online and Manage Thyroid ... EXCEMED - combine the world,s top expertise with ...
(Date:7/3/2015)... -- A global continuing medical education provider ... disorders in Latin America through ... to these diseases.      (Logo: http://photos.prnewswire.com/prnh/20150630/227033) , ... Hypertension Online and Manage Thyroid Online ... - combine the world,s top expertise with dynamic learning ...
Breaking Medicine Technology:Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5Combating Three Major Chronic Diseases in Central and South-East Asia With Medical Education 2Combating Three Major Chronic Diseases in Latin America With Medical Education 2
(Date:7/6/2015)... ... July 06, 2015 , ... Shortly after opening her ... the leading network of doctors working on a lien basis. Dr. Lim had ... , The daughter of two Cambodian refugees, Dr. Lim suffered with back pain herself ...
(Date:7/6/2015)... ... 06, 2015 , ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a ... at a CAGR of over 3.2 percent in the years to come to hit ... mainly spurred by an anticipated launch of a number of promising pipeline candidates and ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... in southern California, has partnered with Woodbridge Walk-In Urgent Care to offer on-site ... and other serious medical conditions. Screenings are affordable and accurate and run about ...
(Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... ... CA area, Carlson & Associates has once again teamed up with Family Emergency ... homeless families to move toward self-sufficiency. FESCO was created especially to provide emergency ...
(Date:7/6/2015)... ... July 06, 2015 , ... The School ... funds to support a three-year effort to reduce rates of diabetes and cardiovascular ... in partnership with the Morehouse School of Medicine’s Prevention Research Center and the ...
Breaking Medicine News(10 mins):Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2
... suffer from musculoskeletal injuries and conditionsLAS VEGAS, Feb. 25 ... and conditions affect our quality of life every day. ... Surgeons, (AAOS) 2009 multimedia Public Service Advertising Campaign is ... scoliosis and preventing injuries in female athletes, knees. ...
... Study finds many children at risk for foot deformity due ... children are wearing shoes that are too small, according to ... of the American Academy of Orthopaedic Surgeons ( ... at high risk for developing serious foot deformities.The study, which ...
... Molecular Oncology (MOLONC) ( http://www.elsevier.com/locate/molonc ), published ... European Biochemical Societies (FEBS), has been accepted by ... Science Citation Index Expanded (SciSearch), Biosis Previews and ... times a year from January 1, 2009) highlights ...
... EAST RUTHERFORD, N.J., Feb. 25 CCA Industries, Inc. ... fiscal year ended November 30, 2008 were $57,457,946, net ... were $0.20. Revenues for the prior year were ... per share were $0.78. Revenues for the fourth ...
... University of Texas M. D. Anderson ... Gamma Knife (R) Perfexion(TM), an advanced ... or more lesions in the head in a ... http://www.newscom.com/cgi-bin/prnh/20090225/CL74742 )"Leksell Gamma Knife Perfexion suits our ...
... Feb. 20 CUREXO Technology Corporation, pioneer in ... products for orthopaedic applications, which is focused on ... has submitted a premarket notification 510(k) application to ... market clearance in the U.S. for use of ...
Cached Medicine News:Health News:The Most Breaking News in the Joint 2Health News:The Most Breaking News in the Joint 3Health News:The Most Breaking News in the Joint 4Health News:If the Shoe Fits...or Does It? 2Health News:If the Shoe Fits...or Does It? 3Health News:Molecular Oncology accepted into Thomson Reuters index 2Health News:CCA Industries, Inc Announces Year End Results 2Health News:CCA Industries, Inc Announces Year End Results 3Health News:M. D. Anderson Cancer Center Acquires Leksell Gamma Knife Perfexion for Targeted Brain Lesion Treatments 2Health News:M. D. Anderson Cancer Center Acquires Leksell Gamma Knife Perfexion for Targeted Brain Lesion Treatments 3Health News:CUREXO Technology Corporation Announces 510(k) Submission to FDA for Total Knee Arthroplasty Application 2
... The optomap is the companys core product. ... used in primary level eye care for the ... It is available on a pay-per-patient examination basis ... with a digital wide-field of view of the ...
... Cardiac Digital Camera is a state-of-the-art, office-based nuclear ... and provides full sized fields of view. ... you need a flexible system that can work ... how the Pulse reduces the costs of adding ...
... same cryoconsole and platform technology as Freezor ... veins. Arctic Circler is an ablation tool ... that rely on medication., ,With its ... the ability to create curvilinear lesions rapidly ...
... Coil is intended for: embolization of those ... their location, or the patient's general medical ... team to be a) very high risk ... b) inoperable.,The GDC is also intended for ...
Medicine Products: